Erika Ungvári

447 total citations
10 papers, 179 citations indexed

About

Erika Ungvári is a scholar working on Molecular Biology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Erika Ungvári has authored 10 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Molecular Medicine. Recurrent topics in Erika Ungvári's work include Bacterial biofilms and quorum sensing (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Erika Ungvári is often cited by papers focused on Bacterial biofilms and quorum sensing (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Erika Ungvári collaborates with scholars based in Hungary, Sweden and Netherlands. Erika Ungvári's co-authors include Ákos Tóth, M. Füzi, Judit Pászti, Hajo Grundmann, Hermı́nia de Lencastre, Teresa Conceição, Willem B. van Leeuwen, Alex van Belkum, Marta Aires-de-Sousa and Péter Horváth and has published in prestigious journals such as Clinical Microbiology and Infection, Journal of Medical Microbiology and Eurosurveillance.

In The Last Decade

Erika Ungvári

10 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika Ungvári Hungary 6 141 104 89 34 18 10 179
Maho Yokoyama United Kingdom 5 100 0.7× 102 1.0× 49 0.6× 39 1.1× 23 1.3× 8 172
Megan R. Earls Ireland 8 219 1.6× 127 1.2× 117 1.3× 44 1.3× 34 1.9× 10 254
Sarah A. Egan Ireland 6 148 1.0× 67 0.6× 82 0.9× 41 1.2× 31 1.7× 8 211
Priscila de Arruda Trindade Brazil 8 182 1.3× 140 1.3× 135 1.5× 37 1.1× 34 1.9× 13 263
G. C. Kedar Spain 7 164 1.2× 153 1.5× 52 0.6× 77 2.3× 35 1.9× 8 281
Gabriel Auger France 7 133 0.9× 46 0.4× 86 1.0× 77 2.3× 24 1.3× 11 167
Raf De Ryck Belgium 5 151 1.1× 87 0.8× 99 1.1× 57 1.7× 37 2.1× 5 206
Vladimir Gostev Russia 9 118 0.8× 112 1.1× 48 0.5× 84 2.5× 50 2.8× 44 253
Danielle Leek United Kingdom 6 95 0.7× 56 0.5× 72 0.8× 22 0.6× 27 1.5× 9 142
Loren Dejoies France 11 174 1.2× 57 0.5× 97 1.1× 77 2.3× 64 3.6× 14 246

Countries citing papers authored by Erika Ungvári

Since Specialization
Citations

This map shows the geographic impact of Erika Ungvári's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Ungvári with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Ungvári more than expected).

Fields of papers citing papers by Erika Ungvári

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Ungvári. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Ungvári. The network helps show where Erika Ungvári may publish in the future.

Co-authorship network of co-authors of Erika Ungvári

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Ungvári. A scholar is included among the top collaborators of Erika Ungvári based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Ungvári. Erika Ungvári is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ungvári, Erika, Zoltán Rádai, Levente Laczkó, et al.. (2025). High Prevalence of Cefiderocol Resistance Among New Delhi Metallo-β-Lactamase Producing Klebsiella pneumoniae High-Risk Clones in Hungary. Antibiotics. 14(5). 475–475. 1 indexed citations
2.
Damjanova, Ivelina, Levente Laczkó, Erika Ungvári, et al.. (2024). Genomic Epidemiology of C2/H30Rx and C1-M27 Subclades of Escherichia coli ST131 Isolates from Clinical Blood Samples in Hungary. Antibiotics. 13(4). 363–363. 5 indexed citations
4.
Laczkó, Levente, Erika Ungvári, Eszter Kaszab, et al.. (2023). Carbapenem-resistant Escherichia coli in Black-headed gulls, the Danube, and human clinical samples: A One Health comparison of contemporary isolates. Journal of Global Antimicrobial Resistance. 35. 257–261. 2 indexed citations
5.
Pál, Károly, et al.. (2021). Occurrence and Characteristics of Staphylococcus aureus in a Hungarian Dairy Farm during a Control Program. Pathogens. 10(2). 104–104. 2 indexed citations
6.
Füzi, M., et al.. (2018). Transmissible silver resistance readily evolves in high-risk clone isolates of Klebsiella pneumoniae. Acta Microbiologica et Immunologica Hungarica. 65(3). 387–403. 13 indexed citations
7.
Glasner, Corinna, Gerlinde Pluister, Henrik Westh, et al.. (2014). Staphylococcus aureus spa type t437: identification of the most dominant community-associated clone from Asia across Europe. Clinical Microbiology and Infection. 21(2). 163.e1–163.e8. 25 indexed citations
8.
Horváth, Andrea, Orsolya Dobay, Ákos Tóth, et al.. (2012). Varying fitness cost associated with resistance to fluoroquinolones governs clonal dynamic of methicillin-resistant Staphylococcus aureus. European Journal of Clinical Microbiology & Infectious Diseases. 31(8). 2029–2036. 30 indexed citations
9.
Tóth, Ákos, et al.. (2011). Phagocytosis and intracellular killing of heterogeneous vancomycin-intermediate Staphylococcus aureus strains. Journal of Medical Microbiology. 61(2). 198–203. 10 indexed citations
10.
Conceição, Teresa, Marta Aires-de-Sousa, M. Füzi, et al.. (2007). Replacement of methicillin-resistant Staphylococcus aureus clones in Hungary over time: a 10-year surveillance study. Clinical Microbiology and Infection. 13(10). 971–979. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026